P
Market Data
$2.02−$0.17 (−7.76%)
PRLD · Last trade
Prev Close
$2.19
Range (30d)
$1.81 – $2.94
Recent Filings
- 8-K14.4 MBPrelude Therapeutics IncJan 9, 7:30 AM ET·0001193125-26-008280
- 10-Q8.9 MBPrelude Therapeutics IncNov 12, 2:15 AM ET·0001193125-25-275887
- 8-K14.7 MBPrelude Therapeutics IncNov 12, 2:07 AM ET·0001193125-25-275871
- 8-K6.9 MBPrelude Therapeutics IncNov 4, 8:53 AM ET·0000929638-25-004115
- 8-K246.9 KBPrelude Therapeutics IncOct 17, 7:40 AM ET·0001193125-25-241968
- 8-K181.8 KBPrelude Therapeutics IncSep 19, 7:41 AM ET·0001193125-25-208187
- 10-Q8.5 MBPrelude Therapeutics IncAug 14, 7:23 AM ET·0000950170-25-108417
- 8-K18.5 MBPrelude Therapeutics IncAug 14, 7:07 AM ET·0000950170-25-108413
- 8-K206.5 KBPrelude Therapeutics IncJun 13, 4:10 PM ET·0000950170-25-086170
- 10-Q7.7 MBPrelude Therapeutics IncMay 6, 4:45 PM ET·0000950170-25-064566
Insiders
10- 667, L.P.Director, 10% Owner
- Babler MartinDirector
- Baker Bros. Advisors (GP) LLCDirector, 10% Owner
- BAKER BROS. ADVISORS LPDirector, 10% Owner
- Baker Brothers Life Sciences LPDirector, 10% Owner
- BAKER FELIXDirector, 10% Owner
- BAKER JULIANDirector, 10% Owner
- Bonita David PDirector, 10% Owner
- Chardonnet LaurentChief Financial Officer
- Combs AndrewChief Chemistry Officer
Tickers
Addresses
business
175 INNOVATION BOULEVARD
WILMINGTON, DE, 19805
mailing
175 INNOVATION BOULEVARD
WILMINGTON, DE, 19805
Former Names
- Prelude Therapeutics Inc.2017-10-20